Sparsentan in immunoglobulin A nephropathy: a profile of its use Young-A HeoConnie Kang Adis Drug Q&A 29 March 2024 Pages: 101 - 108
Treat bipolar depression with atypical antipsychotics and mood stabilisers; new therapies require further study Simon Fung Practical Issues and Updates 11 March 2024 Pages: 109 - 114
Get on top of gout with a fresh look at treatment options Caroline FentonConnie Kang Practical Issues and Updates 04 April 2024 Pages: 115 - 120
Treating paediatric Crohn’s disease is challenging but new treatments hold promise Tina Nie Disease Management 28 March 2024 Pages: 121 - 126
Be aware of the risks of nephrotoxicity when prescribing amoxicillin and third-generation cephalosporins Amy Zhuang-Yan Drug Reactions and Interactions 21 March 2024 Pages: 127 - 130
What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings? Andrea BushTina BennyMatthew Seamon Current Opinion 28 March 2024 Pages: 131 - 136
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use Tina Nie Correction Open access 21 March 2024 Pages: 137 - 137
Correction to: Efanesoctocog alfa in hemophilia A: a profile of its use Simon FungHannah A. Blair Correction Open access 21 March 2024 Pages: 138 - 138
